Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Trying to predict what the SP will do on a daily basis.
I wasn’t overly worried by the resignation news today but to be honest I did expect the SP to drop a bit on that news.
What do I know though?? Hopefully the rise continues today.
Pretty poor not to have had some sort of update. The Board set shareholder expectations when the said mid-May for an FCA decision. They were praised when the put out proactive comms advising of the delay.
I appreciate the decision and the time it takes for this to be made is out of their hands but given it’s now 12th June I don’t think it’s unreasonable to get an update on why the delay and at least an estimate of a more realistic timescale.
As someone heavily burned in Synairgen recently I would take some profit if this rose to a level you’re happy with and let some ride.
You might regret not maximising your investment but better than seeing it all wash away if failure happens. No matter how unlikely you think that might be there is always a chance.
@theboyg - maybe a question for the AGM rather than for this board.
Like many I’m still hurting from the SPRINTER results and annoyed at the handling of things from the company.
Strangely though, had they released the in vitro results then I may have been in a worse position as many of us on this board would have taken it as a sure sign of success to come and pumped more money in.
They have made a complete arse of everything!
Publishing jobs when results were unknown but not announcing trial results which were known.
If anything this is now just a long term hold to try and salvage something but ideally it needs taken off the SNG team as they don’t know what they’re doing here.
I could almost copy and paste what you’ve written Trek as found myself in exactly the same position.
I was in a fortunate position as what I had invested is pretty much covered by a pay rise I am due to get in April. I appreciate others are not so fortunate though and I really feel for some of the holders, especially those I’ve gotten to know a bit over the last couple of years through this board. It wasn’t the ending we deserved (caveat about possibly not being the end).
If Poly knew more than us then they wouldn’t have bought so many shares around the 175p average - they would have waited and hoovered up today.
You could argue that maybe Polar saw this coming as they had a better overview of the Covid market - or that’s my understanding given where they normally invest.
Either way though, it’s all hindsight and second guessing at the moment.
Remember this is top line data.
Once they drill down, you might start seeing differences by country. For example you don’t know if all patients in US were administered other drugs, or which countries this did take place.
Once they get down to lower levels of granularity that should become clear and help them move forward. The big problem is that nothing with Synairgen has ever happened quickly, so how long might that level of analysis take?
They’ll take your shares because there are still people looking at the ‘positives’ and perhaps willing to buy at this price.
Just because MM’s will take your shares that they sold to you at 180 or 190 a couple of weeks ago, for 28p or whatever now, doesn’t mean they have access to any other information.
Not sure about that AJ.
This could, someday, get back to 3 figures. Likely to be a long time away though and you might be missing other opportunities while waiting here.
No easy answers about what is best to do at the minute.